LMB In The News

RSS feed of lmb-in-the-news posts

British biotech Heptares snapped up by Japan’s Sosei in $400m deal

The Telegraph

The Telegraph reports that the LMB spin-out company Heptares has been acquired by Japanese pharmaceutical company Soseito. The group’s research and development activities and 72 employees will remain in Hertfordshire, and Heptares will operate as an autonomous subsidiary to Sosei. Heptares is developing a string of drugs using a technology which can determine the precise shape of the target molecule, originally developed in the LMB. Its most advanced drug, which aims to treat Alzheimer’s, recently entered human trials. More…


Lab land: architectural portrait of LMB


Architectural photographer, David Porter, explores LMB for Cambridge Business magazine, pages 65-69. More…


DNA Sequencing technique featured on Royal Mail stamp


The DNA Sequencing technique, developed by Fred Sanger at the MRC Laboratory of Molecular Biology, is highlighted as one of eight key inventions of the past century, on a new set of stamps, ‘Inventive Britain’ from the Royal Mail. More…


Basic research could lead to fertility improvements, says LMB’s Melina Schuh

Cambridge News

The Cambridge News highlights Melina Schuh’s work on the development of mammalian oocytes into fertilisable eggs. Errors during this process are common causes of miscarriages and genetic defects such as Down’s syndrome. More…


Venki Ramakrishnan at World Economic Forum in Davos


The end of the antibiotic age? The LMB’s Venki Ramakrishnan took part in a panel discussion on the problem of antibiotic resistance at the World Economic Forum in Davos. In an interview with Katia Moskvitch, he tells us about the importance of gaining a better understanding of the use and misuse of these drugs. More…


Who made these covers and what are they doing here?


A cover image designed by Stephen Wallace from Jason Chin’s group at the LMB and Paul Margiotta from the LMB’s visual aids department is included in the Royal Society of Chemistry blog on cover art and the people who make it. More…


‘Hairclip’ protein mechanism explained

University Of Cambridge

A new study, involving LMB researchers and former LMB group leader, Sarah Teichmann, describes a fundamental mechanism regulating a protein’s shape and function, with potential applications in biotechnology and drug development. More…


Sjors Scheres named by Nature as one of ten people who mattered in 2014


LMB group leader Sjors Scheres is profiled by Nature as one of its ten people of the year, for his work on bringing the cell’s molecular machines into sharper focus, with the use of cryo-EM. More…


Heptares Therapeutics granted key patents for GPCR-Focused Drug Discovery Platform

MRC Technology

Heptares Therapeutics, a leading G protein-coupled receptor (GPCR) structure-guided drug discovery company, has recently been granted multiple key patents in the USA. GPCRs are a superfamily of drug receptors linked to a wide range of human diseases and Heptares was founded in 2007 to develop and commercialise pioneering research from the LMB and the National Institute of Medical Research (NIMR) to find new medicines targeting GPCRs. Sir John Saville presented the inventors with a memento to mark the award of these key patents for the GPCR-focused drug discovery platform. More…


LMB’s Pat Edwards interviewed for the Long and Short magazine


Pat Edwards discusses her role in Research Support at the LMB and why the LMB is such a special place to work. More…